Show simple item record

dc.contributor.authorPiotrowski, Jędrzej
dc.contributor.authorTimler, Małgorzata
dc.contributor.authorKozłowski, Remigiusz
dc.contributor.authorStasiak, Arkadiusz
dc.contributor.authorStasiak, Joanna
dc.contributor.authorBissinger, Andrzej
dc.contributor.authorTimler, Dariusz
dc.contributor.authorTimler, Wojciech
dc.contributor.authorMarczak, Michał
dc.contributor.authorZałuska, Roman
dc.contributor.authorPiotrowski, Grzegorz
dc.date.accessioned2022-01-28T16:46:15Z
dc.date.available2022-01-28T16:46:15Z
dc.date.issued2021-12-06
dc.identifier.issn2039-7275
dc.identifier.other34940006
dc.identifier.otherPMC8700386
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/333308
dc.description.abstract(1) Our study aimed to look at the clinical characteristics, treatment and short-term outcomes of patients hospitalized due to heart failure with coexisting cancer. (2) Methods: Seventy one cancer (Ca) patients and a randomly selected 70 patients without Ca, hospitalized due to heart failure exacerbation in the same time period constituted the study group (Ca patient group) and controls (non-Ca group), respectively. Data on clinical characteristics were collected retrospectively for both groups. (3) Results: Cancer patients presented with a less advanced NYHA class, had more frequent HFpEF, a higher peak troponin T level, and smaller left atrium size, as compared with controls. The in-hospital deaths of Ca patients were associated with: a higher New York Heart Association (NYHA) class, lower HgB level, worse renal function, higher K and AST levels, presence of diabetes mellitus, and HFpEF. By multivariate logistic regression analysis, impaired renal function was the only independent predictor of in-hospital death in Ca patients (OR-1.15; CI 1.05; 1.27); p = 0.017). The following covariates entered the regression: NYHA class, HgB, GFR, K+, AST, diabetes mellitus t.2, and HFpEF. (4) Conclusions: The clinical picture and the course of heart failure in patients with and without cancer are different.
dc.languageeng
dc.publisherMDPI AG
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourcenlmid: 101563282
dc.sourceessn: 2039-7283
dc.subjectCancer
dc.subjectTreatment
dc.subjectHeart Failure
dc.subjectShort-term Outcome
dc.titleClinical Characteristics, Treatment, and Short-Term Outcome in Patients with Heart Failure and Cancer.
dc.typeArticle
dc.date.updated2022-01-28T16:46:14Z
prism.endingPage941
prism.issueIdentifier4
prism.publicationNameClin Pract
prism.startingPage933
prism.volume11
dc.identifier.doi10.17863/CAM.80731
dcterms.dateAccepted2021-11-29
rioxxterms.versionofrecord10.3390/clinpract11040107
rioxxterms.versionVoR
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0/
dc.contributor.orcidKozłowski, Remigiusz [0000-0003-2781-5341]
dc.contributor.orcidStasiak, Arkadiusz [0000-0002-7953-4739]
dc.contributor.orcidTimler, Dariusz [0000-0002-5415-5660]
dc.contributor.orcidZałuska, Roman [0000-0001-6408-3843]
dc.identifier.eissn2039-7283
cam.issuedOnline2021-12-06


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International